NASDAQ:MACK
Merrimack Pharmaceuticals, Inc.
- Stock
Last Close
15.13
17/05 19:59
Market Cap
223.97M
Beta: 1.80
Volume Today
922.50K
Avg: 70.31K
PE Ratio
−152.04
PFCF: −135.35
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 101K - | 1.91M 1,790.10% | 9.14M 378.55% | 7.33M 19.79% | 51K 99.30% | ||||||
average payables | 2.20M - | 3.78M 71.83% | 4.22M 11.56% | 3.14M 25.64% | 1.96M 37.47% | 652.50K 66.72% | 197K 69.81% | 121.50K 38.32% | 154K 26.75% | 131K 14.94% | |
average receivables | 4.58M - | 4.90M 6.83% | 11.98M 144.51% | 8.78M 26.65% | 50K 99.43% | ||||||
book value per share | -9.78 - | -16.52 68.84% | -20.04 21.31% | 7.28 136.32% | 4.41 39.42% | 1.30 70.59% | 1.20 7.73% | 1.06 11.54% | 1.42 34.49% | 1.31 7.88% | |
capex per share | -0.58 - | -1.15 98.70% | -0.25 78.08% | -0.07 72.53% | -0.01 87.21% | ||||||
capex to depreciation | -1.87 - | -2.98 59.28% | -0.50 83.07% | -0.18 65.29% | -0.03 83.47% | ||||||
capex to operating cash flow | 0.17 - | 0.12 29.99% | 0.02 84.73% | 0.01 66.17% | 0.00 71.31% | ||||||
capex to revenue | -0.06 - | -0.14 143.96% | -0.02 84.74% | ||||||||
cash per share | 11.88 - | 16.67 40.31% | 1.72 89.70% | 7.06 311.19% | 5.34 24.35% | 1.24 76.76% | 1.05 15.50% | 1.06 0.97% | 1.44 35.68% | 1.32 8.16% | |
days of inventory on hand | 29.49K - | 768.55 97.39% | |||||||||
days payables outstanding | 40.06K - | 178.70 99.55% | |||||||||
days sales outstanding | 11.77 - | 26.51 125.28% | 44.20 66.71% | ||||||||
debt to assets | 0.76 - | 1.10 44.85% | 3.24 195.33% | 0.17 - | |||||||
debt to equity | -1.18 - | -1.40 19.08% | -1.05 24.96% | 0.25 - | |||||||
dividend yield | 0.00 - | 1.31 - | 0.63 - | ||||||||
earnings yield | -0.09 - | -0.21 138.23% | -0.38 76.45% | 4.43 1,273.46% | -1.00 122.56% | -0.51 49.37% | -0.03 93.50% | -0.05 42.58% | -0.01 78.73% | -0.01 38.18% | |
enterprise value | 1.01B - | 764.24M 24.54% | 597.65M 21.80% | 13.21M 97.79% | 35.36M 167.67% | 25.48M 27.93% | 78.15M 206.69% | 38.22M 51.10% | 135.55M 254.66% | 185.76M 37.05% | |
enterprise value over ebitda | -15.29 - | -5.91 61.35% | -6.07 2.78% | -0.15 97.61% | -0.56 284.36% | -1.07 91.33% | -15.17 1,322.09% | -13.85 8.70% | -51.75 273.76% | -85.37 64.95% | |
ev to operating cash flow | -29.10 - | -7.25 75.07% | -3.51 51.60% | -0.09 97.42% | -0.54 495.58% | -0.81 50.69% | -16.90 1,980.04% | -175.31 937.52% | -77.81 55.62% | -122.05 56.86% | |
ev to sales | 9.86 - | 8.56 13.13% | 4.14 51.62% | -304.60 - | |||||||
free cash flow per share | -3.91 - | -10.61 171.22% | -13.84 30.40% | -11.10 19.78% | -4.92 55.63% | -2.35 52.30% | -0.35 85.29% | -0.02 95.30% | -0.13 692.17% | -0.11 17.36% | |
free cash flow yield | -0.04 - | -0.17 287.94% | -0.43 152.52% | -1.38 219.47% | -1.62 17.64% | -0.75 53.96% | -0.05 93.27% | -0.00 91.71% | -0.01 170.28% | -0.01 29.38% | |
graham net net | -12.85 - | -20.32 58.11% | -23.32 14.77% | 5.48 123.51% | 3.11 43.18% | 1.03 66.79% | 0.99 4.12% | 1.02 2.60% | 1.39 36.99% | 1.29 7.51% | |
graham number | 41.90 - | 70.27 67.70% | 73.88 5.14% | 76.42 3.44% | 17.35 77.29% | 6.82 60.72% | 2.47 63.79% | 2.09 15.40% | 1.91 8.43% | 1.56 18.36% | |
income quality | 0.42 - | 0.71 71.13% | 1.11 55.55% | 2.49 124.11% | 1.08 56.69% | 1.47 37.04% | 1.53 3.56% | 0.09 94.19% | 1.13 1,170.56% | 1.29 14.23% | |
intangibles to total assets | 0.07 - | 0.05 34.66% | 0.09 99.41% | 0 100% | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -3.63 - | -6.74 85.37% | -2.52 62.54% | -2.76 9.52% | -68.59 2,381.83% | -14.63 78.67% | 9.20 - | ||||
interest debt per share | 13.25 - | 24.87 87.61% | 24.54 1.29% | 2.62 89.33% | 1.19 54.70% | 0.11 90.35% | -0.01 - | ||||
inventory turnover | 0.01 - | 0.47 3,737.57% | |||||||||
invested capital | -1.18 - | -1.40 19.08% | -1.05 24.96% | 0.25 - | |||||||
market cap | 928.31M - | 692.19M 25.44% | 402.31M 41.88% | 106.65M 73.49% | 40.56M 61.97% | 42.06M 3.70% | 92.19M 119.17% | 52.42M 43.14% | 154.99M 195.65% | 191.75M 23.72% | |
net current asset value | -128.63M - | -217.18M 68.84% | -276.71M 27.41% | 74.00M 126.74% | 46.38M 37.33% | 15.92M 65.67% | 15.77M 0.93% | 14.12M 10.48% | 19.24M 36.24% | 18.74M 2.58% | |
net debt to ebitda | -1.27 - | -0.56 56.31% | -1.98 256.34% | 1.03 151.69% | 0.08 92.00% | 0.69 745.47% | 2.72 292.60% | 5.15 88.90% | 7.42 44.23% | 2.75 62.92% | |
net income per share | -7.98 - | -13.29 66.56% | -12.11 8.88% | 35.67 394.64% | -3.04 108.51% | -1.59 47.54% | -0.23 85.79% | -0.18 19.09% | -0.11 37.65% | -0.08 27.66% | |
operating cash flow per share | -3.33 - | -9.46 183.80% | -13.58 43.57% | -11.03 18.81% | -4.92 55.43% | -2.35 52.21% | -0.35 85.29% | -0.02 95.30% | -0.13 692.17% | -0.11 17.36% | |
payables turnover | 0.01 - | 2.04 22,319.24% | |||||||||
receivables turnover | 31.02 - | 13.77 55.61% | 8.26 40.01% | ||||||||
research and ddevelopement to revenue | 1.35 - | 1.80 33.82% | 1.12 38.16% | ||||||||
return on tangible assets | -0.57 - | -0.66 16.88% | -2.05 210.75% | 4.02 295.94% | -0.46 111.37% | -1.06 131.49% | -0.18 82.96% | -0.17 7.78% | -0.08 53.24% | -0.06 20.93% | |
revenue per share | 9.84 - | 8.02 18.55% | 11.51 43.61% | -0.03 - | |||||||
roe | 0.82 - | 0.80 1.35% | 0.60 24.88% | 4.90 711.33% | -0.69 114.05% | -1.23 78.38% | -0.19 84.60% | -0.17 8.53% | -0.08 53.64% | -0.06 21.47% | |
roic | -3.52 - | -1.71 51.46% | -7.83 357.70% | -0.64 91.85% | -0.79 23.71% | -1.21 52.93% | -0.18 85.07% | -0.17 3.26% | -0.09 48.41% | -0.12 30.28% | |
sales general and administrative to revenue | 0.30 - | -4.89 - | |||||||||
shareholders equity per share | -9.78 - | -16.52 68.84% | -20.04 21.31% | 7.28 136.32% | 4.41 39.42% | 1.30 70.59% | 1.20 7.73% | 1.06 11.54% | 1.42 34.49% | 1.31 7.88% | |
stock based compensation to revenue | 0.13 - | 0.17 33.91% | 0.10 40.09% | -0.16 - | |||||||
tangible asset value | -113.40M - | -194.65M 71.65% | -260.24M 33.70% | 96.28M 137.00% | 58.82M 38.91% | 17.31M 70.57% | 16.01M 7.54% | 14.19M 11.36% | 19.25M 35.67% | 18.75M 2.60% | |
tangible book value per share | -10.86 - | -17.48 60.94% | -20.76 18.79% | 7.28 135.04% | 4.41 39.42% | 1.30 70.59% | 1.20 7.73% | 1.06 11.54% | 1.42 34.49% | 1.31 7.88% | |
working capital | 20.95M - | 97.65M 366.01% | -30.79M 131.53% | 75.27M 344.48% | 61.31M 18.55% | 15.92M 74.03% | 15.77M 0.93% | 14.12M 10.48% | 19.24M 36.24% | 18.74M 2.58% |
All numbers in USD (except ratios and percentages)